Deerfield Management’s Neos Therapeutics, Inc NEOS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-320,993
| Closed | -$201K | – | 164 |
|
|
2020
Q4 | $201K | Hold |
320,993
| – | – | ﹤0.01% | 128 |
|
|
2020
Q3 | $170K | Hold |
320,993
| – | – | ﹤0.01% | 104 |
|
|
2020
Q2 | $220K | Hold |
320,993
| – | – | 0.01% | 92 |
|
|
2020
Q1 | $241K | Hold |
320,993
| – | – | 0.01% | 89 |
|
|
2019
Q4 | $485K | Hold |
320,993
| – | – | 0.02% | 75 |
|
|
2019
Q3 | $475K | Hold |
320,993
| – | – | 0.02% | 92 |
|
|
2019
Q2 | $414K | Sell |
320,993
-1,478,148
| -82% | -$2.72M | 0.01% | 97 |
|
|
2019
Q1 | $4.7M | Buy |
1,799,141
+568,874
| +46% | +$1.33M | 0.18% | 73 |
|
|
2018
Q4 | $2.03M | Buy |
+1,230,267
| New | +$3.45M | 0.08% | 90 |
|
|
2018
Q3 | – | Sell |
-233,332
| Closed | -$1.46M | – | 122 |
|
|
2018
Q2 | $1.46M | Sell |
233,332
-631,574
| -73% | -$4.71M | 0.05% | 113 |
|
|
2018
Q1 | $7.18M | Buy |
864,906
+119,139
| +16% | +$1.14M | 0.25% | 93 |
|
|
2017
Q4 | $7.61M | Sell |
745,767
-823,154
| -52% | -$7.9M | 0.3% | 76 |
|
|
2017
Q3 | $14.4M | Buy |
1,568,921
+109,726
| +8% | +$834K | 0.65% | 50 |
|
|
2017
Q2 | $10.7M | Sell |
1,459,195
-639,971
| -30% | -$4.83M | 0.57% | 51 |
|
|
2017
Q1 | $15.1M | Buy |
2,099,166
+1,870,000
| +816% | +$11.6M | 0.58% | 54 |
|
|
2016
Q4 | $1.34M | Hold |
229,166
| – | – | 0.06% | 98 |
|
|
2016
Q3 | $1.51M | Sell |
229,166
-229,166
| -50% | -$1.82M | 0.07% | 83 |
|
|
2016
Q2 | $4.25M | Hold |
458,332
| – | – | 0.17% | 76 |
|
|
2016
Q1 | $4.95M | Hold |
458,332
| – | – | 0.21% | 71 |
|
|
2015
Q4 | $6.56M | Hold |
458,332
| – | – | 0.27% | 73 |
|
|
2015
Q3 | $9.63M | Buy |
+458,332
| New | +$10.1M | 0.37% | 72 |
|
Deerfield Management's NEOS Position: Q1 2021 in Review
Deerfield Management sold out of Neos Therapeutics, Inc (NEOS) in Q1 2021, closing a stake of 320,993 shares — an estimated $201K sold.
Deerfield Management first reported a position in NEOS in Q3 2015 and held it in 21 quarters. The position peaked at $15.1M in Q1 2017. 0 funds tracked by Wall St. Rank hold NEOS as of Q1 2021.
- Deerfield Management reported no remaining Neos Therapeutics, Inc position as of Q1 2021 after selling out during the quarter.
- Deerfield Management sold 320,993 Neos Therapeutics, Inc shares in Q1 2021, an estimated $201K.
- Deerfield Management first reported a position in Neos Therapeutics, Inc in Q3 2015 and held it in 21 quarters.
- Deerfield Management's Neos Therapeutics, Inc position peaked at $15.1M in Q1 2017.
- 0 funds tracked by Wall St. Rank held Neos Therapeutics, Inc as of Q1 2021.
Based on Deerfield Management's 13F filing for Q1 2021, filed 17 May 2021.